miR-613 inhibits gastric cancer progression through repressing brain derived neurotrophic factor

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNA-613 (miR-613) is a known tumor suppressor in various cancers.
• Its specific role and mechanism in gastric cancer (GC) remain largely uncharacterized.

Purpose of the Study:

• To investigate the expression, biological function, and molecular mechanism of miR-613 in gastric cancer.
• To determine if miR-613 acts as a tumor suppressor in GC and identify its direct targets.

Main Methods:

• Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) for miR-613 expression analysis.
• Gain-of-function assays (MTT and Transwell) to assess effects on GC cell proliferation, migration, and invasion.
• Luciferase reporter assay to validate brain-derived neurotrophic factor (BDNF) as a direct target of miR-613.

Main Results:

• miR-613 expression was significantly downregulated in GC tissues compared to adjacent non-cancerous tissues.
• Low miR-613 expression correlated with lymph node metastasis and advanced tumor-nodes-metastasis (TNM) stage.
• Overexpression of miR-613 suppressed GC cell proliferation, migration, and invasion.
• BDNF was identified as a direct target of miR-613, with its expression upregulated and inversely correlated with miR-613 levels in GC tissues.
• Knockdown of BDNF mimicked the tumor-suppressive effects of miR-613.

Conclusions:

• miR-613 functions as a tumor suppressor in gastric cancer by directly targeting and downregulating BDNF.
• miR-613 holds potential as a therapeutic target for gastric cancer treatment.